VITAMINE K1 CHEPLAPHARM 2 mg/0,2 ml NOURRISSONS, solution buvable et injectable

solution buvable et injectable · intramusculaire / intraveineuse / orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution buvable et injectable

Routeintramusculaire / intraveineuse / orale

Ingredient entries1

CountryFrance

Product identity

At a glance

Authorisation holder: CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 64337140

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for VITAMINE K1 CHEPLAPHARM 2 mg/0,2 ml NOURRISSONS, solution buvable et injectable
Ingredient	Strength / reference	Source role
PHYTOMÉNADIONEsolution	2 mgune ampoule de 0,2 ml	SAGroup 1

Pack references

Presentations (2)

1 ampoule(s) de 0,2 ml en verre brun avec pipette(s) doseuse(s) polypropylène

CIP13 3400930122303

Présentation active · Déclaration de commercialisation

5 ampoule(s) de 0,2 ml en verre brun avec 5 pipettes doseuses polypropylène

CIP13 3400934864636

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 64337140 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →